Survey of pharmacists' attitudes towards interchangeable use of dry powder inhalers

Pharmacy World and Science

Volumn 29, Issue 3, 2007, Pages 221-227

  Williams, Angela E ^a   Chrystyn, Henry ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Asthma; Generic substitution; Inhalation devices; Pharmacists' perceptions; Web questionnaire

Indexed keywords

ARTICLE; AUSTRALIA; CANADA; COMPUTER AIDED DESIGN; COMPUTER ANALYSIS; CONFUSION; DRUG DELIVERY SYSTEM; DRUG USE; DRY POWDER; FRANCE; GERMANY; HUMAN; INHALER; INTERVIEW; NORMAL HUMAN; PATIENT COMPLIANCE; PHARMACIST ATTITUDE; QUESTIONNAIRE; RESPIRATORY CARE; UNITED KINGDOM; WORKLOAD;

ADMINISTRATION, INHALATION; AEROSOLS; ASTHMA; ATTITUDE OF HEALTH PERSONNEL; BRONCHODILATOR AGENTS; DATA COLLECTION; EQUIPMENT AND SUPPLIES; EQUIPMENT DESIGN; HUMANS; NEBULIZERS AND VAPORIZERS; PATIENT COMPLIANCE; PHARMACISTS; POWDERS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; THERAPEUTIC EQUIVALENCY; TREATMENT OUTCOME; WORKLOAD;

EID: 34249900984     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-006-9079-6     Document Type: Article

References (22)

1. Chrystyn H. Do patients show the same level of adherence with all dry powder inhalers? Int J Clin Pract 2005;59(Suppl 149):19-25
2. Labris NR, Dolovich MB. Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. J Clin Pharmacol 2003;56:600-12
3. Gustafsson P, Taylor A, Zanen P, Chrystyn H. Can patients use all dry powder inhalers equally well? Int J Clin Pract 2005;59(Suppl 149):13-8
4. Buchanan A, Pinnock H, Barnes J et al. Generic prescribing of breath actuated and dry powder inhalers in the UK. Prim Care Respir J 2002;11:95
5. Bisgaard H. Future options for aerosol delivery to children. Allergy 1999;54:97-103
6. Taylor A, Gustafsson P. Do all dry powder inhalers show the same pharmaceutical performance?. Int J Clin Pract 2005;59(Suppl 149):7-12
7. Pritchard JN. The influence of lung deposition on clinical response. J Aerosol Med 2001;14(S1):S19-S26
8. Bateman ED, Silins V, Bogolubov M. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 mcg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma. Respir Med 2001;95:136-46
9. BTS/SIGN (British Thoracic Society/Scottish Intercollegiate Guidelines Network). British guideline on the management of asthma. Thorax 2003;58(suppl 1):i1-i94
10. GINA (Global Initiative for asthma). Pocket guide for asthma management and prevention. http://www.ginasthma.com/Guidelineitem.asp?l1=2&l2= 1&intId=988
11. Thomas M, Williams AE. Are outcomes the same with all dry powder inhalers? Int J Clin Pract 2005;59(Suppl 149):33-5
12. Price D. Do healthcare professionals think that dry powder inhalers can be used interchangeably? Int J Clin Pract 2005;59(Suppl 149): 26-9
13. Booker R. Do patients think that dry powder inhalers can be used interchangeably? Int J Clin Pract 2005;59(Suppl 149): 30-2
14. Barnes PJ, Jonsson B, Klim JB. The costs of asthma. Eur Respir J 1996;9:636-42
15. Hoskins G, McCowan C, Neville RG et al. Risk factors and costs associated with an asthma attack. Thorax 2000;55:19-24
16. Adams WP, Puchikian G, Taylor AS, Patel RM, Burke GP, Williams RL. Regulatory aspects of modification to innovator bronchodilator metered dose inhalers and development of generic substitutes. J Aerosol Med 1994;7:119-34
17. Price D, Summers M, Zanen P. Could interchangeable use of dry powder inhalers affect patients?. Int J Clin Pract 2005;59(Suppl 149):3-6
18. Wood KM, Boath EH, Mucklow JC, Blenkinsopp A. Changing medication: general practitioner and patient perspectives. Int J Phar Pract 1997;5:176-84
19. Zermansky AG, Petty DR, Raynor DK, Lowe CJ, Freemantle N, Vail A. Clinical medication review by a pharmacist of patients on repeat prescriptions in general practice: a randomized controlled trial. Health Technol Assess 2002;6:1-86
20. Vidgren M, Kärkkäinen A, Karjalainen P et al. Effect of powder inhaler design on drug deposition in the respiratory tract. Int J Pharm 1988;42:211-6
21. Thorsson L, Edsbacker S. Less variability in lung deposition of budesonide via Turbuhaler than of fluticasone via Diskus/Accuhaler and pMDI in adults. Am J Respir Crit Care Med 2003;167(Suppl 7):A896
22. Kesten S, Zive K, Chapman KR. Pharmacist knowledge and ability to use inhaled medication delivery systems. Chest 1993;104:1737-42